We are equally committed to providing fast and efficient services to all of our customers, ensuring that from start to finish everything is taken care during the testing stages.
Found in cannabis products, Cannabinoids are chemical compounds that join the cannabinoid receptors of the human body and brain. Along with Cannabidiol (CBD), Cannabichromene (CBC), Tetrahydrocannabivarin (THCV) and Tetrahydrocannabinol (THC), these comprise most of the psychoactive compounds (dozens of which that have been already found to exist) that are naturally present in the cannabis plant (Cannabis sativa L) and could be present in the extract or isolate.
By carrying this out, it will help to more accurately determine the correct amount of dosage needed for extracts and isolates to help verify the quality of the cannabinoid for providers with the reliable data complied.
Notorious for their carcinogenic properties and toxicity, certain chemicals and solvents are found and remain in the product after the extraction process is carried out. It is therefore important to measure the toxicity of any solvents and chemicals before such a product can be up for retail.
The ICH Q3C Guideline regulations ensure this practice is carried out regularly when dealing with residual solvents and dividing them into three classes via Permitted Daily Exposure (PDE) to determine their varying levels of toxicity during the testing process.
Terpenes and terpenoids are the primary organic constituents of essential oils of many plants and flowers. There are varying bio-active proprieties from researching terpenes, some of which are known to be successful such as inducing sleep, mental stimulation and relieving anxiety.
Furthermore, with growing evidence and studies, terpenes found in cannabis products can influence the effects that Tetrahydrocannabinol (THC) and Cannabidiol (CBD) can have on the endocannabinoid system when consumed for medicinal purposes, thereby improving the effectiveness of pain relief or against human diseases. Therefore, it is im portant to identify the correct strain of terpene for consumers and retailers. Such ongo ing analysis helps to aid them by selectively modulating the strain of terpene for maxi mum benefits.
Found as trace levels in various types of raw plants and finished cannabis, Mycotoxins are toxic secondary metabolite compounds produced by mould or fungi that can affect cannabis plants that are used in the production of cannabis products. Through required regular testing, the mycotoxin levels need to be detected and complied to help protect and ensure potential consumers health and safety during and after the testing process.
with increasingly stringent controls and regulations, it is essential that comprehensive pesticide residues testing is carried out in various matrices, to greatly ensure that your products are safe. Pesticides are poisonous and can lead to potential harm more than just the pests at which they are targeted
Any companies supplying and selling CBD who are applying for the Novel Food Application must have all their products analysed for the following:
The CBD market is still very unregulated in the UK with various items not containing CBD at all, THC levels being higher than the 1mg legal limit and even heavy metals/chemicals being put into consumable items that could be potential ly harmful to customers. With the new CBD Novel Food Application (legally enforced as of 31st March 2021) it will ensure better quality products are available within the market through tighter regulations.
All UK CBD products selling such items must now submit a Novel Foods Application as they are subject to Food laws. This however does not apply to any topical products which have to comply with the cosmetic regulations. Since the March 31st deadline, only products with validated applications are now allowed to stay on shelves.
